Medicines, shaken and stirred: A critical review on the ecotoxicology of pharmaceutical mixtures

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 369, Issue 1656, 2014, Pages

  Backhaus, Thomas ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Concentration addition; Independent action; Mixture ecotoxicology; Synergism

Indexed keywords

CONCENTRATION (COMPOSITION); CRITICAL ANALYSIS; ECOTOXICOLOGY; EMPIRICAL ANALYSIS; MEDICINE; POLLUTION MONITORING; SOIL BIOTA;

DRUG; DRUG COMBINATION; POLLUTANT;

ANIMAL; CHEMISTRY; DRUG COMBINATION; ECOTOXICOLOGY; POLLUTANT; TOXICITY;

ANIMALS; DRUG COMBINATIONS; ECOTOXICOLOGY; ENVIRONMENTAL POLLUTANTS; PHARMACEUTICAL PREPARATIONS;

EID: 84907834090     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2013.0585     Document Type: Review

References (72)

1. Kostich MS, Batt AL, Lazorchak JM. 2014 Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ. Pollut. 184, 354-359. (doi: 10. 1016/j. envpol. 2013. 09. 013).
2. Andreozzi R, Raffaele M, Nicklas P. 2003 Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50, 1319-1330. (doi: 10. 1016/S0045-6535(02)00769-5).
3. Jelić A, Petrović M, Barceló D. 2009 Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/quadrupole-linear ion trap mass spectrometry. Talanta 80, 363-371. (doi: 10. 1016/j. talanta. 2009. 06. 077).
4. McClellan K, Halden RU. 2010 Pharmaceuticals and personal care products in archived U. S. biosolids from the 2001 EPA national sewage sludge survey. Water Res. 44, 658-668. (doi: 10. 1016/j. watres. 2009. 12. 032).
5. Vulliet E, Cren-Olivé C. 2011 Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environ. Pollut. 159, 2929-2934. (doi: 10. 1016/j. envpol. 2011. 04. 033).
6. Proia L, Osorio V, Soley S, Köck-Schulmeyer M, Pérez S, Barceló D, Romaní AM, Sabater S. 2013 Effects of pesticides and pharmaceuticals on biofilms in a highly impacted river. Environ. Pollut. 178, 220-228. (doi: 10. 1016/j. envpol. 2013. 02. 022).
7. Vazquez-Roig P, Andreu V, Blasco C, Picó Y. 2012 Risk assessment on the presence of pharmaceuticals in sediments, soils and waters of the Pego-Oliva Marshlands (Valencia, eastern Spain). Sci. Total Environ. 440, 24-32. (doi: 10. 1016/j. scitotenv. 2012. 08. 036).
8. Kostich MS, Batt AL, Glassmeyer ST, Lazorchak JM. 2010 Predicting variability of aquatic concentrations of human pharmaceuticals. Sci. Total Environ. 408, 4504-4510. (doi: 10. 1016/j. scitotenv. 2010. 06. 015).
9. Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS. 2011 Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 45, 75-92. (doi: 10. 1016/j. watres. 2010. 08. 019).
10. Boxall ABA, Ericson J. 2012 Environmental fate of human pharmaceuticals. In Human pharmaceuticals in the environment (eds BW Brooks, DB Huggett), pp. 63-84. New York, NY: Springer.
11. Boxall ABA. 2008 Fate of veterinary medicines applied to soils. In Pharmaceuticals in the environment, 2nd edn (ed K. Kümmerer), pp. 103-120. New York, NY: Springer.
12. Challis JK, Hanson ML, Friesen KJ, Wong CS. 2014 A critical assessment of the photodegradation of pharmaceuticals in aquatic environments: defining our current understanding and identifying knowledge gaps. Environ. Sci. Process. Impacts 16, 672-696. (doi: 10. 1039/c3em00615h).
13. LaLone CA, Berninger JP, Villeneuve DL, Ankley GT. 2014 Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms. Phil. Trans. R. Soc. B 369, 20140022. (doi: 10. 1098/rstb. 2014. 0022).
14. Hutchinson TH, Madden JC, Naidoo V, Walker CH. 2014 Comparative metabolism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuticals. Phil. Trans. R. Soc. B 369, 20130583. (doi: 10. 1098/rstb. 2013. 0583).
15. Doerr-MacEwen NA, Haight ME. 2006 Expert stakeholders' views on the management of human pharmaceuticals in the environment. Environ. Manage. 38, 853-866. (doi: 10. 1007/s00267-005-0306-z).
16. Boxall ABA et al. 2012 Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ. Health Perspect. 120, 1221-1229. (doi: 10. 1289/ehp. 1104477).
17. Jia J, Zhu F, Ma X, Cao Z, Cao ZW, Li Y, Li YX, Chen YZ. 2009 Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov. 8, 111-128. (doi: 10. 1038/nrd2683).
18. Brodin T, Piovano S, Fick J, Klaminder J, Heynen M, Jonsson M. 2014 Ecological effects of pharmaceuticals in aquatic systems-impacts through behavioural alterations. Phil. Trans. R. Soc. B 369, 20130580. (doi: 10. 1098/rstb. 2013. 0580).
19. Van den Brink PJ, Crum SJH, Gylstra R, Bransen F, Cuppen JGM, Brock TCM. 2009 Effects of a herbicide-insecticide mixture in freshwater microcosms: risk assessment and ecological effect chain. Environ. Pollut. 157, 237-249. (doi: 10. 1016/j. envpol. 2008. 07. 012).
20. Brain RA et al. 2004 Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum. Aquat. Toxicol. 70, 23-40. (doi: 10. 1016/j. aquatox. 2004. 06. 011).
21. Richards SM, Wilson CJ, Johnson DJ, Castle DM, Lam M, Mabury SA, Sibley PK, Solomon KR. 2004 Effects of pharmaceutical mixtures in aquatic microcosms. Environ. Toxicol. Chem. 23, 1035-1042. (doi: 10. 1897/02-616).
22. Wilson CJ, Brain RA, Sanderson H, Johnson DJ, Bestari KT, Sibley PK, Solomon KR. 2004 Structural and functional responses of plankton to a mixture of four tetracyclines in aquatic microcosms. Environ. Sci. Technol. 38, 6430-6439. (doi: 10. 1021/es049766f).
23. Rosi-Marshall EJ, Kincaid DW, Bechtold HA, Royer TV, Rojas M, Kelly JJ. 2013 Pharmaceuticals suppress algal growth and microbial respiration and alter bacterial communities in stream biofilms. Ecol. Appl. 23, 583-593. (doi: 10. 1890/12-0491. 1).
24. Galus M, Jeyaranjaan J, Smith E, Li H, Metcalfe C, Wilson JY. 2013 Chronic effects of exposure to a pharmaceutical mixture and municipal wastewater in zebrafish. Aquat. Toxicol. 132-133, 212-222. (doi: 10. 1016/j. aquatox. 2012. 12. 016).
25. Madureira TV, Rocha MJ, Cruzeiro C, Rodrigues I, Monteiro RAF, Rocha E. 2012 The toxicity potential of pharmaceuticals found in the Douro River estuary (Portugal): evaluation of impacts on fish liver, by histopathology, stereology, vitellogenin and CYP1A immunohistochemistry, after sub-acute exposures of the zebrafish model. Environ. Toxicol. Pharmacol. 34, 34-45. (doi: 10. 1016/j. etap. 2012. 02. 007).
26. Vannini C, Domingo G, Marsoni M, De Mattia F, Labra M, Castiglioni S, Bracale M. 2011 Effects of a complex mixture of therapeutic drugs on unicellular algae Pseudokirchneriella subcapitata. Aquat. Toxicol. 101, 459-465. (doi: 10. 1016/j. aquatox. 2010. 10. 011).
27. Ginebreda A, Muñoz I, de Alda ML, Brix R, López-Doval J, Barceló D. 2010 Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ. Int. 36, 153-162. (doi: 10. 1016/j. envint. 2009. 10. 003).
28. Backhaus T, Karlsson M. 2014 Screening level mixture risk assessment of pharmaceuticals in STP effluents. Water Res. 49, 157-165. (doi: 10. 1016/j. watres. 2013. 11. 005).
29. Quinn B, Gagné F, Blaise C. 2009 Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuata. Sci. Total Environ. 407, 1072-1079. (doi: 10. 1016/j. scitotenv. 2008. 10. 022).
30. Dietrich S, Ploessl F, Bracher F, Laforsch C. 2010 Single and combined toxicity of pharmaceuticals at environmentally relevant concentrations in Daphnia magna: a multigenerational study. Chemosphere 79, 60-66. (doi: 10. 1016/j. chemosphere. 2009. 12. 069).
31. Dietrich S, Dammel S, Ploessl F, Bracher F, Laforsch C. 2010 Effects of a pharmaceutical mixture at environmentally relevant concentrations on the amphipod Gammarus fossarum. Mar. Freshw. Res. 61, 196-203. (doi: 10. 1071/MF09048).
32. Pomati F, Castiglioni S, Zuccato E, Fanelli R, Vigetti D, Rossetti C, Calamari D. 2006 Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ. Sci. Technol. 40, 2442-2447. (doi: 10. 1021/es051715a).
33. Chou T. 2006 Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621-681. (doi: 10. 1124/pr. 58. 3. 10.).
34. Scholze M, Boedeker W, Faust M, Backhaus T, Altenburger R, Grimme LH. 2001 A general best-fit method for concentration-response curves and the estimation of low-effect concentrations. Environ. Toxicol. Chem. 20, 448-457. (doi: 10. 1002/etc. 5620200228).
35. Bliss C. 1939 The toxicity of poisons applied jointly. Ann. Appl. Biol. 26, 585-615. (doi: 10. 1111/j. 1744-7348. 1939. tb06990. x).
36. Backhaus T, Faust M. 2012 Predictive environmental risk assessment of chemical mixtures: a conceptual framework. Environ. Sci. Technol. 46, 2564-2573. (doi: 10. 1021/es2034125).
37. Kortenkamp A, Backhaus T, Faust M. 2009 State of the art report on mixture toxicity. Report to the EU Commission. Available at http://ec. europa. eu/environment/chemicals/pdf/report_Mixture%20 toxicity. pdf.
38. Backhaus T, Faust M, Blanck H. 2010 Hazard and risk assessment of chemical mixtures under REACH. State of the art, gaps and options for improvement. Report to the Swedish Chemicals Inspectorate. Sundbyberg, Sweden: KEMI.
39. Backhaus T, Scholze M, Grimme L. 2000 The single substance and mixture toxicity of quinolones to the bioluminescent bacterium Vibrio fischeri. Aquat. Toxicol. 49, 49-61. (doi: 10. 1016/S0166-445X(99)00069-7).
40. Backhaus T, Altenburger R, Boedeker W, Faust M, Scholze M, Grimme LH. 2000 Predictability of the toxicity of a multiple mixture of dissimilarly acting chemicals to Vibrio fischeri. Environ. Toxicol. Chem. 19, 2348-2356. (doi: 10. 1002/etc. 5620190927).
41. Cleuvers M. 2003 Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 142, 185-194. (doi: 10. 1016/S0378-4274(03)00068-7).
42. Cleuvers M. 2005 Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 59, 199-205. (doi: 10. 1016/j. chemosphere. 2004. 11. 090).
43. Christensen AM, Faaborg-Andersen S, Ingerslev F, Baun A. 2007 Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans. Environ. Toxicol. Chem. 26, 85-91. (doi: 10. 1897/06-219R. 1).
44. Fent K, Escher C, Caminada D. 2006 Estrogenic activity of pharmaceuticals and pharmaceutical mixtures in a yeast reporter gene system. Reprod. Toxicol. 22, 175-185. (doi: 10. 1016/j. reprotox. 2006. 04. 010).
45. Christensen A. 2006 Ecotoxicity of mixtures of antibiotics used in aquacultures. Toxicol. Chem. 25, 2208-2215. (doi: 10. 1897/05-415R. 1).
46. Brosche S, Backhaus T. 2010 Toxicity of five protein synthesis inhibiting antibiotics and their mixture to limnic bacterial communities. Aquat. Toxicol. 99, 457-465. (doi: 10. 1016/j. aquatox. 2010. 06. 008).
47. Escher BI, Bramaz N, Eggen RIL, Richter M. 2005 In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life. Environ. Sci. Technol. 39, 3090-3100. (doi: 10. 1021/es048590e).
48. Backhaus T, Porsbring T, Arrhenius A, Brosche S, Johansson P, Blanck H. 2011 Single-substance and mixture toxicity of five pharmaceuticals and personal care products to marine periphyton communities. Environ. Toxicol. Chem. 30, 2030-2040. (doi: 10. 1002/etc. 586).
49. Backhaus T, Blanck H, Sumpter J. 2008 On the ecotoxicology of pharmaceutical mixtures. In Pharmaceuticals in the environment, 2nd edn (ed. K Kümmerer), pp. 257-277. New York, NY: Springer.
50. Flaherty CM, Dodson SI. 2005 Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 61, 200-207. (doi: 10. 1016/j. chemosphere. 2005. 02. 016).
51. Eguchi K, Nagase H, Ozawa M, Endoh YS, Goto K, Hirata K, Miyamoto K, Yoshimura H. 2004 Evaluation of antimicrobial agents for veterinary use in the ecotoxicity test using microalgae. Chemosphere 57, 1733-1738. (doi: 10. 1016/j. chemosphere. 2004. 07. 017).
52. Greco WR, Bravo G, Parsons JC. 1995 The search for synergy: a critical review from a response surface perspective. Pharmacol. Rev. 47, 331-385.
53. Schnell S, Bols NC, Barata C, Porte C. 2009 Single and combined toxicity of pharmaceuticals and personal care products (PPCPs) on the rainbow trout liver cell line RTL-W1. Aquat. Toxicol. 93, 244-252. (doi: 10. 1016/j. aquatox. 2009. 05. 007).
54. Brezovšek P, Eleršek T, Filipič M. 2014 Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis. Water Res. 52, 168-177. (doi: 10. 1016/j. watres. 2014. 01. 007).
55. González-Pleiter M, Gonzalo S, Rodea-Palomares I, Leganés F, Rosal R, Boltes K, Marco E, Fernández-Piñas F. 2013 Toxicity of five antibiotics and their mixtures towards photosynthetic aquatic organisms: implications for environmental risk assessment. Water Res. 47, 2050-2064. (doi: 10. 1016/j. watres. 2013. 01. 020).
56. Rodea-Palomares I, Petre AL, Boltes K, Leganés F, Perdigón-Melón JA, Rosal R, Fernández-Piñas F. 2010 Application of the combination index (CI)-isobologram equation to study the toxicological interactions of lipid regulators in two aquatic bioluminescent organisms. Water Res. 44, 427-438. (doi: 10. 1016/j. watres. 2009. 07. 026).
57. Schallenberg M, Armstrong A. 2004 Assessment of antibiotic activity in surface water of the lower Taieri Plain and impacts on aquatic bacteria in Lake Waipori, South Otago, New Zealand. New Zeal. J. Mar. Freshw. Res. 38, 19-28. (doi: 10. 1080/00288330. 2004. 9517214).
58. Sumpter JP, Jobling S. 1995 Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ. Health Perspect. 103(Suppl.), 173-178. (doi: 10. 1289/ehp. 95103s7173).
59. Parente T, Hauser-Davis R. 2013 The use of fish biomarkers in the evaluation of water pollution. In: Pollution and fish health in tropical ecosystems (eds EA de Almeida, CAO Ribeiro), pp. 164-181. Abingdon, UK: CRC Press.
60. Li J, Wang T, Shao B, Shen J, Wang S, Wu Y. 2012 Plasmid-mediated quinolone resistance genes and antibiotic residues in wastewater and soil adjacent to swine feedlots: potential transfer to agricultural lands. Environ. Health Perspect. 120, 1144-1149. (doi: 10. 1289/ehp. 1104776).
61. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. 1995 A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 103, 582-587. (doi: 10. 1289/ehp. 95103582).
62. Baker-Austin C, Wright MS, Stepanauskas R, McArthur JV. 2006 Co-selection of antibiotic and metal resistance. Trends Microbiol. 14, 176-182. (doi: 10. 1016/j. tim. 2006. 02. 006).
63. Muñoz I, López-Doval J. 2009 Bridging levels of pharmaceuticals in river water with biological community structure in the Llobregat river basin (northeast Spain). Environ. Toxicol. Chem. 28, 2706-2714. (doi: 10. 1897/08-486. 1).
64. Damásio J et al. 2011 Are pharmaceuticals more harmful than other pollutants to aquatic invertebrate species: a hypothesis tested using multi-biomarker and multi-species responses in field collected and transplanted organisms. Chemosphere 85, 1548-1554. (doi: 10. 1016/j. chemosphere. 2011. 07. 058).
65. Proia L et al. 2013 Response of biofilm bacterial communities to antibiotic pollutants in a Mediterranean river. Chemosphere 92, 1126-1135. (doi: 10. 1016/j. chemosphere. 2013. 01. 063).
66. Brack W et al. 2014 The SOLUTIONS project: challenges and responses for present and future emerging pollutants in land and water resources management. Sci. Total Environ. (doi: 10. 1016/j. scitotenv. 2014. 05. 143).
67. Johnson AC, Sumpter JP. 2014 Putting pharmaceuticals into the wider context of challenges to fish populations in rivers. Phil. Trans. R. Soc. B 369, 20130581. (doi: 10. 1098/rstb. 2013. 0581).
68. Zhang L, Reynolds KS, Zhao P, Huang S-M. 2010 Drug interactions evaluation: an integrated part of risk assessment of therapeutics. Toxicol. Appl. Pharmacol. 243, 134-145. (doi: 10. 1016/j. taap. 2009. 12. 016).
69. Brown AR, Gunnarsson L, Kristiansson E, Tyler CR. 2014 Assessing variation in the potential susceptibility of fish to pharmaceuticals, considering evolutionary differences in their physiology and ecology. Phil. Trans. R. Soc. B 369, 20130576. (doi: 10. 1098/rstb. 2013. 0576).
70. European Medicines Agency. 2012 Guideline on the Investigation of Drug Interactions CPMP/EWP/560/95/Rev. 1 Corr. Available at http://www. ema. europa. eu/docs/en_GB/document_library/Scientific_guideline/2012/07/WC500129606. pdf.
71. Harris CA, Scott AP, Johnson AC, Panter GH, Sheahan D, Roberts M, Sumpter JP. 2014 Principles of sound ecotoxicology. Environ. Sci. Technol. 48, 3100-3111. (doi: 10. 1021/es4047507).
72. Arnold S, Klotz D, Collins B. 1996 Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272, 1489-1492. (doi: 10. 1126/science. 272. 5267. 1489).